Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins
- 5 February 2024
- journal article
- research article
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 260, 105377
Abstract
No abstract availableKeywords
Funding Information
- Universiti Putra Malaysia
- Kementerian Pendidikan Malaysia (FRGS/1/2018/STG07/UPM/02/4)
This publication has 52 references indexed in Scilit:
- Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticlesActa Pharmaceutica Sinica B, 2021
- Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarbBiomedicine & Pharmacotherapy, 2020
- Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanismsThe International Journal of Biochemistry & Cell Biology, 2020
- Temperature triggering of kinetically trapped self-assemblies in citrem-phospholipid nanoparticlesChemistry and Physics of Lipids, 2018
- Cubosomes: The Next Generation of Smart Lipid Nanoparticles?Angewandte Chemie International Edition, 2018
- 25-Hydroxycholesterol and inflammation in Lovastatin-deregulated mevalonate pathwayThe International Journal of Biochemistry & Cell Biology, 2017
- Statin Use for the Primary Prevention of Cardiovascular Disease in AdultsJAMA, 2016
- New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?Cardiovascular Drugs and Therapy, 2013
- Phospholipids and Lipid-Based Formulations in Oral Drug DeliveryPharmaceutical Research, 2010
- The antioxidative function, preventive action on disease and utilization of proanthocyanidinsBioFactors, 2004